EUVIMEDScopri EUVIMED
Open access · CC BY-NC 4.0

Harnessing Cross-Reactive CD8 + T RM Cells for Long-Standing Protection Against Influenza A Virus

Ida Uddbäck, Jacob E Kohlmeier, Allan R Thomsen, Jan P Christensen

Viral Immunology · 2020-04 · 33 (3) · 201-207

DOI: 10.1089/vim.2019.0177 ↗

At a glance

Journal article in Viral Immunology, published online on 2020-04-15. Written by Ida Uddbäck and 3 co-authors. Institution: Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. Major MEDLINE topics: Cross Reactions, Immunologic Memory. Cited 10 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

As of today, influenza A virus infection is very much a health issue for the human population. Over a 100 years have passed since the 1918 influenza pandemic that caused the deaths of tens of millions of people over the world, but despite this we have not been able to develop an efficient vaccine that can protect the population. Since they first became available, >60 years ago, commercial vaccines all primarily induce an antibody response targeting the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). The vaccine is the most effective method of protecting the population against influenza infection available today, nevertheless the U.S. Centers for Disease Control and Prevention estimated the efficiency to be ranging between 20% and 60% over the last years (12,33,40,48,60). The major underlying reason for this is the ever-evolving influenza A virus. Genetic drift results in changes of the surface proteins, making it impossible for antibodies to recognize and neutralize newly evolved virus. As a result, there is an annual need for re-evaluation and possibly re-formulation of the vaccine in an attempt to match the circulating strains. An alternative to the antibody-mediated immunity, targeting the variable HA and NA, is to induce cellular immunity targeting the highly conserved internal influenza proteins. Nineteen years ago from Peter C. Doherty’s laboratory, Christensen et al. published a study illustrating the capacity and critical role of CD8 T cells in heterosubtypic protection, an article that has become one of the cornerstones when discussing the important role of CD8 T cells in cross protection against respiratory viruses (8). The data presented in that article clearly demonstrated that by generating a large number of influenza-specific CD8 T cells, protection against influenza A challenge was improved, not only against homosubtypic strains, but also against heterosubtypic influenza strains where seroimmunity was lacking. Specifically, the T cell immune response was boosted by re-infection with serologically different influenza strains that shared the same CD8 T cell nucleoprotein (NP) epitope. When an influenzaspecific CD8 T cell population was present before challenge, limited expansion of the CD8 T cell population was required, thus not only protecting against the virus infection but also limiting immunopathology. The article also illustrated that pre-existing cellular immunity have limitations. Despite high numbers of cross-reactive CD8 T cells, present as early as 1-day postchallenge, viral titers did not differ from groups with no T cell immunity. This pinpointed another important fact, the CD8 T cell response will first be activated after the influenza virus has infected its host. Since this publication in 2000, substantial effort has been put into understanding the basic foundations necessary for designing a vaccine generating a long-lasting cross-protective CD8 T cell population.

Subjects

MeSH terms (MEDLINE)

Cross ReactionsImmunologic MemoryAnimalsCD8-Positive T-LymphocytesGenetic DriftHumansInfluenza A virusInfluenza VaccinesInfluenza, HumanOrthomyxoviridae Infections

Author keywords

adenovirusinfluenzamemorytissue resident memory cellsvaccines

Substances

Influenza Vaccines

Authors and institutions

  • Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia.
  • Emory-UGA Center of Excellence for Influenza Research and Surveillance, Atlanta, Georgia.

Cite

APA

Uddbäck, I., Kohlmeier, J. E., Thomsen, A. R., & Christensen, J. P. (2020). Harnessing Cross-Reactive CD8 + T RM Cells for Long-Standing Protection Against Influenza A Virus. Viral Immunology, 33(3), 201-207. https://doi.org/10.1089/vim.2019.0177

Vancouver

Uddbäck I, Kohlmeier JE, Thomsen AR, Christensen JP. Harnessing Cross-Reactive CD8 + T RM Cells for Long-Standing Protection Against Influenza A Virus. Viral Immunology. 2020;33(3):201-207. doi:10.1089/vim.2019.0177

BibTeX
@article{Uddbck2020,
  author = {Uddbäck, Ida and Kohlmeier, Jacob E and Thomsen, Allan R and Christensen, Jan P},
  title = {Harnessing Cross-Reactive CD8 + T RM Cells for Long-Standing Protection Against Influenza A Virus},
  journal = {Viral Immunology},
  year = {2020},
  volume = {33},
  number = {3},
  pages = {201--207},
  doi = {10.1089/vim.2019.0177}
}
Start for free →